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ABSTRACT 
Radioloigand binding techniques were used in combination with in vivo -- 
electrophysiological recording to characterize changes in beta 
adrenoreceptor activity in various brain areas in rats treated chronically 
with morphine. Following chronic morphine treatment, the maximum number of 
specific binding sites for 3H-dihydroalprenolol (3H-DHA) in parietal 
cortex and hippocampus showed a biphasic change, indicating an initial 
increase and decrease (relative to controls) in beta adrenoreceptors in 
these regions with time during withdrawal. No appreciable changes were 
observed in the dissocation constants for 3H-DHA binding. The changes in 
cortical beta adrenoreceptor density found in early (8 hr) and later phases 
(32 hr) of withdrawal were paralled by a selective increase and decrease, 
respectively, in cortical neuron sensitivity to noradrenerglc stimulation. 
These result8 suggest a possible linkage between changes in central 
adrenoreceptor function and the formation and/or expression of opiate 
dependence. 
INTRODUCTION 
Considerable evidence indicates that significant components of the 
opiate withdrawal syndrome may be due to increased central noradrenergic 
activity. For example, activation of the locus coeruleus (LC) in subhuman 
primates by means of either electrical or pharmacological stimulation 
elicits a profile of behavioral and physiological effects strikingly similar 
to those observed during opiate withdrawal (1). Both morphine and 
clonidine, an alpha2 adrenerglc agonist, have been shown to block these 
effects of LC activation (1) and to suppress the acceleration in LC neuron 
firing and norepinephrine (NE) turnover in brain that occurs during acute 
opiate withdrawal (1,2). Clonidine has also been shown to alleviate opiate 
withdrawal symptoms in animals and man (3); an effect which has been 
attributed to its inhibitory influence on LC-NE neuronal activity. These 
findings have served to focus attention on central noradrenergic neurons, 
particularly those of the LC, as a "final common pathway" for the 
manifestation of the opiate abstinence syndrome. Nevertheless, the finding 
in recent studies of Increases and decreases in beta and alpha2 adrenergic 
receptors, respectively, in various brain regions in rata treated 
chronically with morphine (4,5,6) raises the additional possibility that 
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changes in central adrenoreceptor function may contribute to or reinforce 
the effects occurring in opiate-sensitive noradrenergic neurons. In the 
present study, radioligand binding techniques were used in conjunction with 
in vlvo electrophysiological recording to determine whether changes in brain -- 
beta adrenoreceptors that result from chronic morphine treatment are 
reflected in corresponding alterations in postsynaptic neuronal sensitivity 
to noradrenergic stimulation. Experiments were carried out during early and 
late stages of morphine withdrawal to assess the possible relationship of 
changes in central adrenorceptor function to the abstinence syndrome. 
METHODS 
Groups of eight Sprague-Dawley male rats (175-2258) were injected with 
morphine sulfate or saline, i.p., every 8 hr for 14 days, with the dosage of 
the narcotic ranging from 10 mg/kg, t.i.d., on the first 3 days to 100 
mg/bg, t.l.d., on the last 2 days. Animals used for the binding assays were 
killed by decapitation either 8 hr (chronic treatment group) or 32 hr 
(withdrawal group) after the last injection and homogenates prepared from 
the parietal cortex, hippocampus, and cerebellum. The brain areas isolated 
from six rats were homogenized in 5 ml of ice-cold 5mM Tris-sucrose buffer 
(pH 7.4), centrifuged at 1000 x g for 1 min, and the supernates were saved 
and re-centrifuged at 40,000 x g. The crude membrane pellet was then 
re-homogenized in the same buffer and centrifuged again at 40,000 x g. The 
final pellet was resuspended in 50 mt4 Tris-incubation buffer adjusted to pH 
8.0. For the determination of total beta adrenergic receptor binding, 1 ml 
aliquots of the neural membranes were incubated in duplicate for 30 min at 
25°C with various concentrations of 3H-DHA (.l - 25.6nM range, sp. act. 
34.1 Ci/mmol). Nonspecific binding was determined by addition of propranol 
10’5~ to the incubation. The incubations were terminated by rapid 
filtration under vacuum through Whatman GF/C glass fiber filters and by 
washing with two 10 ml aliquots of Tris-incubation buffer at 25OC. 
The remaining animals from each morphlne- and saline-treatment group 
were prepared for in vivo electrophyaiological recording at the same time -- 
that the binding assays were initiated. Following induction of anesthesia 
with halothane (0.75% In air), the rats were fixed in a sterotaxic frame and 
a craniotomy performed to expose a 2mm x 3mm circumscribed area of the 
parietal cortex. Five-barreled glass microplpets (3-5 megohm) were used to 
record extracellularly the discharge of single identified cerebrocortical 
neurons and to apply chemical substances In their immediate vicinity by 
microiontophoresis. The neural signals were amplified and displayed using 
conventional techniques and ratemeter records of spike discharge constructed 
to determine neuronal chemosensitivlty to the following test substances: 
0.5 M l-NE, pH 4.0, 0.25 M 1-isoproterenol (ISO), pH 4.5 and .lM GADA, pH 
3.5. Changes in postsynaptic adrenoreceptor sensitivity following prolonged 
opiate treatment were assessed by comparing the mean threshold current of 
iontophoretlcally applied NE required to Inhibit the spontaneous firing of 
cerebrocortical neurons recorded in chronic morphine-treated and 
morphine-withdrawn rats versus saline-treated controls. 
RFSDLTS 
Chronic administration of morphine resulted in significant increases in 
the maximum number of specific binding sites (Dmax) for 3H-DHA in the 
30 
parietal cortex (33.93, p<.OOO5) and hippocampus (12.8X, p<.O6), but not in 
cerebellum. This enhancement in 3H-DHA binding was observed 8 hr 
following cessation of morphine treatment. In comparison, there was a 
marked reduction in the maximum number of 31i-DHA binding sites in parletal 
cortex (-14.7X, p~.O05) and hippocampus (-26,4X;, P-LOOS) during late 
wlthdrawaI. These changes in beta receptor number occurred without 
appreciable change in the KD'S for 3%DHA binding and were not observed 
following acute treatment of rats with morphine 30 mg/kg, t.i.d., for 1 day. 
Mlcrolontophoretic testing revealed that the changes In 3H-DBA binding 
found in parletal cortex during early (8 hr) and later phases (32 hr) of 
withdrawal were paralleled by a concomitant Increase and decrease, 
respectively, in postsynaptic sensitivity of cerebrocortlcal neurons to 
noradrenerglc stlwilatlon (Fig. 1). In tests on 46 cell-pairs from 13 
experiments, the mean threshold currents of NE (27.3 + 1.4nA, S.E.M.) and 
IS0 (25.1 + 2.0 nA, S.E.M.) required for depression 03 neurons In chronic 
morphine-treated rats were significantly less (p<.OOl) than those of control 
cells (41.5 + 1.9 nA, NE; 41.1 + 2.3 nA, ISO). In subsequent experiments 
(NE12) on 31 cell-pairs, slgnlflcantly higher (~~001) levels of 
lontophoretlc NE (45.9 + 2.1 nA, mean + S.E.M.) and IS0 (49.2 + 2.4nA, mean 
+ S.E.M.) were required-to inhibit the-firing of neurons recorded in 32 hr 
Glthdrawn rats compared to cells in saline-treated controls (23.0 + 1.4 nA, 
NE; 30.7 2 1.6nA, ISO). No significant differences In chemosensltlvlty to 
the direct Inhibitory effects of GABA were observed between cells recorded 
in control, chronic morphine-treated and withdrawn animals. 
Fig. 1. Continuous ratemeter records from an experiment comparing 
responsiveness to lontophoretlcally applied NE (thick bars), IS0 (thin bars) 
and GABA (dashed lines) between cerebrocortlcal neurons from a saline 
control (A), chronic morphine-treated (B) and morphine-withdrawn rat (C). 
The cells recorded from the morphine-treated (B) and morphine-withdrawn 
animal (C) show a higher and lower sensitivity, respectively, to the 
inhibitory actions of both NE and IS0 than does the control cell (A). 
DISCUSSION 
The results of this study confirm and extend earlier findings (4,s) that 
chronic, but not acute, administration of morphine results In an Increased 
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number of beta adrenoreceptors in rat cerebral cortex. Using 
electrophysiological recording methods in combination with radioligand 
binding techniques, we were able to demonstrate that the increase in 
cortical beta adrenoreceptors produced by chronic morphine treatment was 
paralleled by an enhanced responsiveness of cerebrocortical neurons to NE. 
Neurons in chronic morphine-treated animals appeared hypersensitive as well 
to the direct inhibitory action of the beta selective agonist ISO, but not 
to GABA. It seems likely, therefore, that the increase in cerebrocortical 
neuron sensitivity to noradrenergic stimulation following long-term morphine 
administration reflects the emergence of supersensitivity in postsynaptic 
beta adrenoreceptors, rather than alterations in catecholamine re-uptake or 
a nonspecific change in cellular excitability. The time course of this 
observed change in beta receptor activity would support a linkage between 
the occurrence of beta-adrenergic supersensitivity and the opiate dependent 
state. Whether such changes in central adrenoreceptor sensitivity 
contribute in a significant way in the manifestation of the withdrawal 
syndrome, however, remains unclear. The fact that beta adrenoreceptors in 
brain are not increased, but rather markedly reduced, during late withdrawal 
(32 hr) at a time when the primary abstinence syndrome is fully expressed 
suggests that beta adrenergic mechanisms are not crucial to the maintenance 
of opiate withdrawal. 
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